Join Daniel Soffer, MD, a leading internist and lipid specialist and the immediate past president of the National Lipid Association, as he shares groundbreaking advancements in lipid management from the recent NLA meeting. Discover the importance of measuring patient responses, the benefits of combination therapies, and the latest in drug development for tackling lipid disorders.
Use of lipid ratios to predict vascular target organ damage in youth
Source : https://pubmed.ncbi.nlm.nih.gov/38462388/
Arterial stiffness is increased in youth with high lipid ratios with TG/HDL-C being the most consistent marker of vascular changes. These data suggest that identification of high TG/HDL-C in these...
Arterial stiffness is increased in youth with high lipid ratios with TG/HDL-C being the most consistent marker of vascular changes. These data suggest that identification of high TG/HDL-C in these individuals may lead to earlier intervention to prevent atherosclerotic cardiovascular disease.
Lipids as potential mediators linking body mass index to diabetes: evidence from a mediation analysis based on the NAGALA cohort
Source : https://pubmed.ncbi.nlm.nih.gov/38730299/
Our fresh findings suggested that lipid parameters partially mediated the association of BMI with diabetes risk; this result indicated that in the context of diabetes risk screening and disease management,...
Our fresh findings suggested that lipid parameters partially mediated the association of BMI with diabetes risk; this result indicated that in the context of diabetes risk screening and disease management, it is important to not only monitor BMI but also pay attention to lipid parameters, particularly HDL-C and HDL-C-related lipid ratio...
The 2024 National Lipid Association (NLA) Scientific Sessions featured updated guidance on lipid management for women of reproductive age, complex patients, and other special populations. Presentations also included a deep dive on lipoprotein(a) (Lp[a]) in clinical practice as well as potential new blood markers for heart disease risk. The four-day meeting was held at Caesars Palace in Las Vegas.
Held at Caesars Palace in Las Vegas, the 2024 National Lipid Association (NLA) Scientific Sessions span four days and feature updated guidance on lipid management for complex patients and crucial drug interactions in lipid-lowering medications, plus information on clinical trials, challenges with statin tolerance, and other deep dives on the nuances of lipidology.


